• Skip to primary navigation
  • Skip to main content

Aggie Research Programs

Texas A&M University

  • Research Leadership
  • Undergraduates
  • Project List
  • Team Leader Resources
  • Contacts
  • Calendar
  • FAQs
  • Show Search
Hide Search

Spring 2024: Staphylococcus epidermidi infection in AML Patients

Affiliations: Genetics & Genomics Research Leadership
Project Leader: Stephanie McMahon

stephmcm@tamu.edu

Veterinary Pathobiology

Faculty Mentor: Jessica Galloway-Pena, Ph.D.
Meeting Times:
TBA
Team Size:
4
Open Spots: 0
Special Opportunities:
Earn co-authorship on at least one paper, have data to present at undergraduate research presentation opportunities, work towards becoming an undergrad member of the lab, potentially attend local conferences (College Station or Houston)
Team Needs:
Basic biology background, at least one hands-on lab course (with a grade of a B or higher), at least 6 hours of time to dedicate to lab work, any coding/R knowledge is a bonus and highly sought out, best to understand things such as PCR and basic bacteria information (gram stain, aerobic vs anaerobic, streaking a plate)
Description:
My project goal is to utilize metagenomics and microbiome studies to inform a patient’s treatment plan and decrease susceptibility to infection, specifically by Staphylococcus epidermidis. S. epidermidis has been shown to account for 20% of bloodstream infections in acute myeloid leukemia (AML) patients and is emerging as a pathogen representing an unstable microbiome. The overall objective of this proposal is to garner a better understanding of the competitive mechanisms bacteria in the microbiome use to prevent opportunistic infection to potentially develop therapeutic targets. Additionally, I will adopt mouse models to better understand how specific antibiotics, in tandem with chemotherapy, perturbate the gut microbiome and influence the translocation of S. epidermidis leading to subsequent sepsis. Ultimately, I hypothesize that the susceptibility to S. epidermidis infection can be mediated by microbes present in a patient’s GI tract, as well as by regimens of antibiotics in the presence of chemotherapy.

Written by:
América Soto-Arzat
Published on:
December 12, 2023

Categories: FullTags: Spring 2024

Footer

Texas A&M University  |  Web Accessibility  |  Site Policies  |  Site Support

© 2021, Website by CVMBS Communications, Texas A&M College of Veterinary Medicine & Biomedical Sciences